A Prophet for predicting cancer treatment

Israel’s Oncohost (reported here previously) presented the results of its latest proteomic (proteins) cancer study to the Society for Immunotherapy of Cancer’s (SITC). Oncohost’s PROphet host response profiling platform can predict the best therapy to use for specific cancer patients.




This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *